The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary


Briton Fights for Self-Destruct Syringes in Tanzania

November 2, 2011

A British entrepreneur and designer of an auto-disable (AD) syringe is on a mission to get such devices widely adopted to prevent syringe re-use, which can transmit infectious diseases such as HIV and hepatitis B and C. Tanzania is one of the countries using the AD syringes, said Marc Koska, founder of SafePoint, a charity that advocates for the use of any quality-assured brand of AD syringe.


A 2000 World Health Organization study estimated 23 million hepatitis B and C transmissions were attributable to unsafe injection practices each year, costing $119 billion in annual medical costs and lost productivity. Koska hopes to persuade four other east African countries to use AD syringes before taking on the global market.

The largest procurer of routine childhood immunizations, UNICEF, provides safe syringes along with the vaccines, Koska noted. But that leaves out "the other 90 percent" of injections, he said.

At £0.03 (US $0.05) apiece, syringes are cheap to manufacture. A small number of large companies make them, bundling them as a loss leader with other higher-margin products. AD syringes can be made cheaply made after initially expensive changes in the production process.

With Koska's AD syringe, the plunger breaks upon attempted re-use. Three billion have been sold.

Back to other news for November 2011

Adapted from:
The Guardian (London)
10.29.2011; Sarah Boseley

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
See Also
Quiz: Are You at Risk for HIV?
10 Common Fears About HIV Transmission

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: